Not all segments of the laboratory testing industry are pushing intensely to oppose an expected attempt to reintroduce legislation restoring the 20% patient co-payment for Medicare Part B lab testing services. (See TDR, May 27, 2003.) Sources tell THE DARK REPORT that some of the more powerful lab organizations believe competitive advantage will accrue to […]
To access this post, you must purchase The Dark Report.